-
1
-
-
36148940587
-
The ongoing regulation of generic drugs
-
Frank R.G. The ongoing regulation of generic drugs. New Engl J Med 357 (2007) 1993-1996
-
(2007)
New Engl J Med
, vol.357
, pp. 1993-1996
-
-
Frank, R.G.1
-
2
-
-
0032938160
-
A review of the safety of generic drugs
-
Dighe S.V. A review of the safety of generic drugs. Transplant Proc 31 suppl 3A (1999) 23S-24S
-
(1999)
Transplant Proc
, vol.31
, Issue.SUPPL. 3A
-
-
Dighe, S.V.1
-
3
-
-
0029861308
-
Generic drugs. Therapeutic equivalence
-
Meredith P.A. Generic drugs. Therapeutic equivalence. Drug Safety 15 (1996) 233-242
-
(1996)
Drug Safety
, vol.15
, pp. 233-242
-
-
Meredith, P.A.1
-
4
-
-
0024461363
-
Status of generic substitution: problematic drug classes reviewed
-
Ross M.B. Status of generic substitution: problematic drug classes reviewed. Hosp Formul 24 (1989) 441-449
-
(1989)
Hosp Formul
, vol.24
, pp. 441-449
-
-
Ross, M.B.1
-
5
-
-
0028235940
-
Comparative bioavailability of a generic phenytoin and Dilantin
-
Rosenbaum D.H., Rowan A.J., Tuchman L., et al. Comparative bioavailability of a generic phenytoin and Dilantin. Epilepsia 35 (1994) 656-660
-
(1994)
Epilepsia
, vol.35
, pp. 656-660
-
-
Rosenbaum, D.H.1
Rowan, A.J.2
Tuchman, L.3
-
6
-
-
85136372677
-
-
Dong BJ, Walter HW, Gambertoglio JG, et al. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. 1997;277:1205-13.
-
Dong BJ, Walter HW, Gambertoglio JG, et al. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. 1997;277:1205-13.
-
-
-
-
7
-
-
21744437458
-
Are brand-name and generic warfarin interchangeable?. Multiple N-of-1 randomized, crossover trials
-
Pereira J.A., Holbrook A.M., Dolovich L., et al. Are brand-name and generic warfarin interchangeable?. Multiple N-of-1 randomized, crossover trials. Ann Pharmacol 39 (2005) 1188-1193
-
(2005)
Ann Pharmacol
, vol.39
, pp. 1188-1193
-
-
Pereira, J.A.1
Holbrook, A.M.2
Dolovich, L.3
-
8
-
-
18844441250
-
Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded randomized, crossover study
-
Lee H.L., Kan C.D., and Yang Y.J. Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded randomized, crossover study. Clin Therapeutics 27 (2005) 309-319
-
(2005)
Clin Therapeutics
, vol.27
, pp. 309-319
-
-
Lee, H.L.1
Kan, C.D.2
Yang, Y.J.3
-
9
-
-
0032914001
-
Understanding bioequivalence testing
-
Benet L.Z. Understanding bioequivalence testing. Transplant Proc 31 Suppl 3A (1999) 7S-9S
-
(1999)
Transplant Proc
, vol.31
, Issue.SUPPL. 3A
-
-
Benet, L.Z.1
-
10
-
-
0003547433
-
-
Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD
-
Approved Drug Products with Therapeutic Equivalence Evaluations. 17th ed. (1997), Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD
-
(1997)
Approved Drug Products with Therapeutic Equivalence Evaluations. 17th ed.
-
-
-
11
-
-
32644435800
-
The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions
-
Shrank W.H., Hoang T., Ettner S.L., et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med 166 (2006) 332-337
-
(2006)
Arch Intern Med
, vol.166
, pp. 332-337
-
-
Shrank, W.H.1
Hoang, T.2
Ettner, S.L.3
|